Application and prospects of gene editing in mosquito-borne disease control
- 1 Nantong University
- 2 Decai Senior High School
- 3 Wanli University
* Author to whom correspondence should be addressed.
Abstract
Mosquito-borne diseases are a threat to about half of the world’s population, the harm caused by it has remained serious in recent years. However, traditional methods of insecticide and environmental control have not completely solved the mosquito problem, and many times they come with certain side effects on environment. At the biological and genetic level, it may be possible to find safe and sustainable ways to alleviate the burden of mosquito-borne pathogens. This study focuses on gene editing technology, introducing CRISPR technology and its development, reviewing recent advancements and their applications on kinds of illness like Dengue fever and COVID-19, discussing the future development of mosquito-borne disease control. Moreover, there are several limitations of CRISPR, to solve them, this review presents ideas that the CRISPR system can combine with Digital twin and achieve a better result in experiment. Against the backdrop of rapid developments in artificial intelligence, many cutting-edge technologies are expected to be applied to gene editing in the future.
Keywords
CRISPR, Mosquito-Borne Diseases, Digital Twin
[1]. Simmonds P, Becher P, Bukh J, et al. ICTV virus taxonomy profile: Flaviviridae. The Journal of General Virology, 98(1):2-3 (2017).
[2]. Guo C C, Zhou Z X, wen Z H, et al. Global epidemiology of dengue outbreaks in 1990—2015: a systematic review and meta-analysis[J]. Frontiers in Cellular and Infection Microbiology, 7:317 (2017).
[3]. Dhimal M, Gautam I, Joshi H D, et al. Risk factors for the presence of chikungunya and dengue vectors (Aedes aegypti and Aedes albopictus), their altitudinal distribution and climatic determinants of their abundance in central Nepal. PLoS Neglected Tropical Diseases, 9(3): e0003545 (2015).
[4]. Yang L, Chen Y, Yan H C, et al. A survey of the 2014 dengue fever epidemic in Guangzhou, China. Emerging Microbes & Infections, 4(9): e57 (2015).
[5]. De wispelaere M, Desprès P, Choumet V. European Aedes albopictus and culex pipiens are competent vectors for Japanese encephalitis virus. PLoS Neglected Tropical Diseases, 11(1): e0005294 (2017).
[6]. Fan Y C, Lin J W, Liao S Y, et al. Virulence of Japanese encephalitis virus genotypes Ⅰand Ⅲ, Taiwan[J/OL]. Emerging Infectious Diseases, 23(11):1883-1886 (2017).
[7]. Park S L, Huang Y J S, Lyons A C, et al. North American domestic pigs are susceptible to experimental infection with Japanese encephalitis virus. Scientific Reports, 8:7951 (2018).
[8]. Ricklin M E, Garcìa-nicolàs O, Brechbühl D, et al. Japanese encephalitis virus tropism in experimentally infected pigs. Veterinary Research, 47:34 (2016).
[9]. Kellner, M.J., Koob, J.G., Gootenberg, J.S.et al.SHERLOCK: nucleic acid detection with CRISPR nucleases. Nat Protoc 14, 2986–3012 (2019).
[10]. Dai, Y. et al. Exploring the trans-cleavage activity of CRISPR–Cas12a (cpf1) for the development of a universal electrochemical biosensor. Angew. Chem. Int. Ed. 58, 17399–17405 (2019).
[11]. Pardee, K. et al. Rapid, low-cost detection of Zika virus using programmable biomolecular components. Cell 165, 1255–1266 (2016).
[12]. Li, S.-Y. et al. CRISPR–Cas12a-assisted nucleic acid detection. Cell Discov. 4, 20 (2018).
Cite this article
Luo,L.;Wang,J.;Wang,L. (2023). Application and prospects of gene editing in mosquito-borne disease control. Theoretical and Natural Science,8,40-45.
Data availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
Disclaimer/Publisher's Note
The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
About volume
Volume title: Proceedings of the 2nd International Conference on Modern Medicine and Global Health
© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and
conditions of the Creative Commons Attribution (CC BY) license. Authors who
publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons
Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this
series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published
version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial
publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and
during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See
Open access policy for details).